AccuStem Sciences, Inc.
ACUT
$0.16
-$0.07-28.89%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -9.94% | -11.09% | 19.54% | 10.24% | 44.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.56% | 10.33% | 38.24% | 21.85% | 44.28% |
| Operating Income | 37.07% | -10.33% | -38.24% | -21.85% | -44.28% |
| Income Before Tax | 37.07% | -10.33% | -38.24% | -21.85% | -44.28% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 37.07% | -10.33% | -38.24% | -21.85% | -44.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.07% | -10.33% | -38.24% | -21.85% | -44.28% |
| EBIT | 37.07% | -10.33% | -38.24% | -21.85% | -44.28% |
| EBITDA | 37.08% | -10.38% | -38.58% | -22.18% | -44.72% |
| EPS Basic | 37.20% | 12.72% | -0.63% | 13.84% | -2.04% |
| Normalized Basic EPS | 37.18% | 12.50% | -0.50% | 13.81% | -1.96% |
| EPS Diluted | 37.20% | 12.72% | -0.63% | 13.84% | -2.04% |
| Normalized Diluted EPS | 37.18% | 12.50% | -0.50% | 13.81% | -1.96% |
| Average Basic Shares Outstanding | 0.00% | 26.32% | 37.43% | 41.65% | 41.65% |
| Average Diluted Shares Outstanding | 0.00% | 26.32% | 37.43% | 41.65% | 41.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |